Skip Navigation LinksAnnouncements
All Announcements

THESIS PROJECT-I TITLES

Published Date: Monday, 10 September 2018

To the attention of students who will be registering for PHAR 451 (Thesis Project-I) in  2018-2019 Fall Semester;

Please find the list of announced THESIS PROJECT TITLES.


PHARMACEUTICAL TOXICOLOGY

Prof. Dr. Gönül ŞAHİN

  1. Organ Toxicity: Liver Toxicity (theoretical)
  2. Organ Toxicity: Renal Toxicity (theoretical)
  3. Extrahepatic Metabolism and it's importance in Toxicity (theoretical)
  4. Risk Assesments (theoretical)
  5. Antidotes (theoretical)
  6. Circadian Toxicology (theoretical)
  7. Cancerogenesis (theoretical)
  8. Cell death: Apoptosis and necrosis and detection in cell culture (practical)
  9. Buffers and their preparations and characteristics (practical)
  10. Urinary Neopterin profile in geriatric groups (practical)

PHARMACEUTICAL TECHNOLOGY GROUP

Asst. Prof. Dr. HASİP CEM ÖZYURT

  1. Orally sedative gel formulation development for PET's  (Experimental)
  2. Effect of commonly used solvents on membrane filter materials (Experimental)
  3. Topical formulation design  for acne  treatment (Experimental)
  4. Radiopharmaceutical's … Compounding, administration and their safety rules (Theoretical)
  5. Pharmaceutical compounding at Hospital Pharmacy (Theoretical)
  6. Geriatric dosage form design….Tips and properties to watch out for.. (Theoretical)

Asst. Prof. Dr. METİN ÇELİK

  1. Pharmaceutical application of nanotechnology.
  2. The impact of Quality by Design (QbD) approach in formulation and process development

 Sr. Instr. LEYLA BEBA

  1. Preparation of ODT (Orally disintegrating tablet) formulations and their dissolution studies.  (J2)
  2. Evaluation of Polaxamer gel bases formulations. (J2)
  3. Artificial neural network for optimization of pharmaceutical formulations.  (J1)
  4. Electrospinning drug delivery.  (J1)

Sr. Instr. EMİNE DİLEK ÖZYILMAZ

  1. The quality control studies on orally disintegrating tablet formulations.  (J2)
  2. In-vitro quantitative drug release studies from different HMPC gel bases formulations. (J2)
  3. Pharmaceutical taste masking technologies for bitter drug.  (J1)
  4. Ocular applications of drug delivery systems.  (J1)

Sr. Instr. MUSTAFA AKPINAR

  1. The natural ımmune system stimulators (theoretical)
  2. The prevention and natural treatments methods for insomnia (theoretical)
  3. The harmful effects of the sun on skin and natural protection ways (theoretical)
  4. The natural methods for hairloss cure and protection (theoretical)

PHARMACEUTICAL CHEMISTRY GROUP

Assoc. Prof. Dr. H. OZAN GÜLCAN

  1. Synthesis and measuring cholinesterase inhibitory potential of (1E,4E)-1,5-bis(4-methoxyphenyl) penta-1,4-dien-3-one. (J2, P)
  2. Synthesis and measuring cholinesterase inhibitory potential of (1E,4E)-1,5-bis(4-(dimethylamino) phenyl)penta-1,4-dien-3-one. (J2, P)
  3. Synthesis and measuring cholinesterase inhibitory potential of (1E,4E)-1,5-bis(4-hydroxyphenyl) penta-1,4-dien-3-one. (J2, P)
  4. Synthesis and measuring cholinesterase inhibitory potential of (1E,4E)-1,5-bis(3,4-dimethoxy phenyl)penta-1,4-dien-3-one. (J2, P)
  5. Synthesis and measuring cholinesterase inhibitory potential of (1E,4E)-1,5-bis(3-hydroxyphenyl) penta-1,4-dien-3-one. (J2, P)
  6. Synthesis and measuring cholinesterase inhibitory potential of (1E,4E)-1,5-bis(3-methoxyphenyl) penta-1,4-dien-3-one. (J2, P)
  7. Dual MAO and cholinesterase inhibitors. (J1, T)

Asst. Prof. Dr. E. VİLDAN BURGAZ

  1. The methods of determination of phenolic compounds in honey using HPLC (Theoretical)
  2. HPLC methods for the determination of amygdaline in the plant seeds (Theoretical)
  3. Synthesis Methods of dihydrofurocoumarins and furocomarins (Theoretical)
  4. Synthesis Methods of dihydrofuroquinoline and furoquinoline (Theoretical)
  5. Synthesis Methods of dihydrofuropyran and furopyran (Theoretical)
  6. Synthesis Methods of Afatinib (Theoretical)

PHARMACOGNOSY GROUP

Prof. Dr. MÜBERRA KOŞAR

  1. Therapeutic usages of essential oils (theoretical)
  2. Medicinal plants used in hair preparations (theoretical)
  3. Medicinal plants used as phytoestrogens (theoretical)
  4. Therapeutic usage of Zingiber officinale (theoretical)
  5. Medicinal plants used in geriatrics (theoretical)
  6. Medicinal plants used in Alzheimer's disease (theoretical)
  7. Aromatherapeutics used as analgesic drugs (theoretical)
  8. Medicinal mashrooms and their usages (theoretical)
  9. Phytoequivalency of gingko preparations from pharmacies in Famagusta (J2- practical)
  10. Ascorbic acid amounts of Rosa canina preparations from pharmacies in Famagusta (J2- practical)

   Prof. Dr. NERİMAN ÖZHATAY

  1. Garlic  (Allium sativum)  taxonomy, cutivation, uses, medicinal importance and garlic product
  2. Bay Laurel  tree (Laurus nobilis ) and Common myrtle (Myrtus communis) taxanomy,    trade, uses in different countries
  3. Oregano species ,taxonomy, trade, uses in different countries
  4. Carob, Harnup (Ceratonia siliqua )taxonomy, distribution,uses, products
  5. Caper (Capparis spinosa ) taxonomy, distribution , cultivation,uses. Products
  6. Sage (  Phlomis species ) in North Cyprus, taxonomy, distribution,uses,local names
  7. Poppy ( Papaver  species) in North Cyprus taxonomy, distribution, , uses, local names
  8. Milk thistle ( Silybum marianum )taxonomy, distribution, uses, trade products
  9. Honey plants of Saint Hileron
  10. Medicinal plant  species used as cardiotonic.

Asst. Prof. Dr. TUĞBA ERÇETİN

      1. Antibacterial and Antiviral Activities of Medicinal Plants in Eastern Mediterranean region (theoretical)

      2. Role of  Biotechnology in Vaccine Development (theoretical)

      3. Lipoxygenase (LOX) and Cyclooxygenase (COX) inhibitory potential of medicinal plants (theoretical)

      4.  Applications of Omics Technologies (proteomics, metabolomics) in Pharmaceutical Sciences (theoretical)

     5.  Applications of Biotechnology in Pharmacy (theoretical)

     6.  Production of secondary metabolites with biotechnological methods (theoretical)

PHARMACOLOGY GROUP

Assoc. Prof. Dr. EMRE HAMURTEKİN

  1. Pharmacological management of osteoarthritis
  2. Local use of antibiotics in dermatological disorders
  3. The use of SSRIs in depression treatment - ***for Turkish speaking students
  4. Use of NSAIDs in hypertensive patients.
  5. Relationship between depression scores in patients with neurodegenerative diseases-***for Turkish speaking students
  6. Patient-related factors in unwanted effects of cardiac glycoside use.
  7. Importance of recording patient's drug history before hospitalization-***for Turkish speaking students


Asst. Prof. Dr. JALE YÜZÜGÜLEN

  1. Investigation of metformin use among type 2 diabetic individuals and comparison of drug adherence to diabetic complications (practical and for Turkish speaking students)
  2. Biomarkers of endothelial damage (theoretical)
  3. The Role of Endothelin-1 in Prostate Cancer (theoretical)
  4. Cardiovascular related adverse effect profiles of chemotherapeutic drugs (theoretical/ practical)

BIOTECHNOLOGY AND MOLECULAR BIOLOGY GROUP

Asst. Prof. Dr. İMGE KUNTER

  1. Organoids and drug discovery in pharmaceutical area (J1)
  2. Biobanking in scientific research area (J1)
  3. Tumor immunology and immunotherapy (J1)
  4. Biosensors and their application (J1)
  5. Microscopic imaging techniques and their usage in research area (J1)
  6. Cell viability and cell motility assays used in pharmaceutical and cancer research (J1 and J2)

MICROBIOLOGY GROUP

Prof. Dr. Gülden YILMAZ

  1. HPV infection awareness( with questionnaire)  - J2
  2. HPV vaccines
  3. HAV vaccination
  4. Mosquito as a vector
  5. HCV treatment
  6. Plaque
  7. Success in smallpox eradication
  8. Ebola
  9. Influenza pandemics
  10. Rubella (systematic review) – J2

Asst. Prof. Dr. MEHMET İLKTAÇ

  1. Antibiotic associated diarrhea: Bacterial agents (theoretical)
  2. Campylobacter infections (theoretical)
  3. Carbapenem resistance in Gram negative bacteria (theoretical)
  4. Microbiological diagnosis of sepsis (theoretical)

PHARMACEUTICAL MANAGEMENT GROUP

Sr. Instr. CANAN GÜLCAN

  1. Cost Minimization Analysis in Healthcare
  2. Medicine Pricing in Developed Countries
  3. Burnout among Pharmacists
  4. The role of Pharmacists in Health Care services 
  5. The role of pharmacoeconomics in the research and development decision-making process

OTHER ACADEMIC STAFF

Eda GEDİKOĞLU

      1.       Side effects and  toxicity monitoring of cancer drugs used in breast cancer

Dr. Bahadır BARBİN

     1.       Use of antibiotics in upper respiratory system infections

      2.       Drugs used in cardiopulmonary resuscitation (CPR)

Eylem İLKTAÇ KÖRCEĞİZ

      1.       Screening for  pre-diabetes/diabetes in community pharmacies in Cyprus (for Turkish speaking students)

      2.       Screening for  hypertension/ cardiovascular risk in community pharmacies in Cyprus (for Turkish speaking students)


  • This list is also found on the ANNOUNCEMENT BOARD in the third floor.
  • Each student should read  the instructions carefully during the process of choosing thesis projects. 
  • You are then asked to fill the THESIS PROJECT FORM that is attached here Thesis Project Form.pdf
  • After you complete the form, please place it into the submission box (7B). 
  • Deadline for the submission of thesis project form is  01.October.2018, 1 pm.
EMU Websites